Anthera Pharmaceuticals (ANTH) Promotes Dr. Debra Odink as CTO

December 5, 2011 5:03 PM EST
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced Dr. Debra Odink has been promoted to the role of Chief Technology Officer and Senior Vice President.

Dr. Odink joined Anthera in 2005 and has been serving as the Senior Vice President of Pharmaceutical Research and Development since that date. She has over eighteen years of global pharmaceutical chemistry and product development experience. Prior to joining Anthera, she served as the Vice President of Product and Process Development at Peninsula Pharmaceuticals.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Management Changes